Skip to main content
. Author manuscript; available in PMC: 2026 Jan 1.
Published in final edited form as: J Urol. 2024 Sep 30;213(1):27–33. doi: 10.1097/JU.0000000000004267

Table 1.

Rates of BCR at 10 years with 95% confidence intervals for those taking testosterone vs not taking testosterone, separately by pathologic Gleason grade group, along with the estimates for testosterone use from the Cox model for BCR. The estimate for grade group 1 patients on testosterone is based on only 1 BCR event.

Grade Group No testosterone Testosterone HR 95% CI p-value
1 5.2% (1.5%, 8.8%) 15% (0%, 37%) 0.84 0.48, 1.46 0.5
2 16% (12%, 20%) 8.9% (0.2%, 17%)
3 40% (27%, 51%) 32% (7.2%, 50%)